Below are the most recent publications written about "Uveal Neoplasms" by people in Profiles.
-
Varney SD, Erkes DA, Mersky GL, Mustafa MU, Chua V, Chervoneva I, Purwin TJ, Alnemri E, Aplin AE. Metabolic Inhibition Induces Pyroptosis in Uveal Melanoma. Mol Cancer Res. 2025 04 01; 23(4):350-362.
-
Calabresi K, Emrich J, Belko S, Pugliese R, Komarnicky-Kocher L, Mourtada F. 3D-printed template design to improve 125I seed plaque assembly accuracy for uveal brachytherapy. Brachytherapy. 2025 May-Jun; 24(3):420-430.
-
August AH, Cernichiaro-Espinosa LA, Moctezuma-Davila M, Wibbelsman TD, Wilson MW, Ch?vez-Barrios P, Shields CL, Lally SE, Eberhart CG, Orr BA, Simpson E, Eagle RC, Milman T. Ciliary Body Medulloepithelioma: Clinical and Pathologic Challenges with a Focus on Molecular Genetics. Semin Ophthalmol. 2025 Aug; 40(6):518-528.
-
Cappelli L, Khan MM, Shields CL, Lally SE, Sharif M, Liu H, Chen Y, Park J, Zhan T, Shi W. Favorable Outcomes of Patients With High-Risk Uveal Melanoma Treated With a Novel Linear Accelerator-Based Frameless Fractionated Stereotactic Radiosurgery. Am J Ophthalmol. 2025 Mar; 271:417-423.
-
Dimitriou F, Orloff MM, Koch Hein EC, Cheng PF, Hughes IF, Simeone E, Montazeri K, Grover P, Mehmi I, Gerard CL, Gaudy-Marqueste C, Grob JJ, Michielin O, Hamid O, Long GV, Sullivan R, Kapiteijn E, Johnson DB, Ascierto PA, Joshua AM, Carvajal RD, Butler MO, Hassel JC, Dummer R. Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumors. Eur J Cancer. 2025 Jan; 214:115161.
-
Sener H, Bansal R, Catapano T, Shields JA, Shields CL. Non-Conditional and Conditional Metastasis of Uveal Melanoma Per Millimeter-By-Millimeter in Thickness in 8034 Patients. Semin Ophthalmol. 2025 Oct; 40(7):642-649.
-
Mourtada F, Belko S, Monane R, Pugliese R, Komarnicky-Kocher L, Lally SE, Wang W, Shields CL, Emrich J. A novel 3D printing method for a notched eye plaque "dummy" for uveal melanoma brachytherapy. Brachytherapy. 2025 Jan-Feb; 24(1):86-91.
-
Dalvin LA, Andrews-Pfannkoch CM, Miley DR, Hogenson TL, Erickson SA, Malpotra S, Anderson KJ, Omer ME, Almada LL, Zhang C, Li H, Salomao DR, Shields CL, Lally SE, Malsch RM, Armitage JA, Holmes HL, Romero MF, Fautsch MP, Markovic SN, Fernandez-Zapico ME. Novel Uveal Melanoma Patient-Derived Organoid Models Recapitulate Human Disease to Support Translational Research. Invest Ophthalmol Vis Sci. 2024 11 04; 65(13):60.
-
Seedor RS, Aplin AE, Bertolotto C, Carvajal RD, Deacon N, Doble K, Hamid O, Haq R, Kadosh M, Khan S, Kraska J, Lutzky J, McKean M, Montazeri K, Moser J, Onken M, Orloff M, Sacco JJ, Smalley K, Selig SM. Meeting Report From the 2023 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Philadelphia, PA, November 2023. Pigment Cell Melanoma Res. 2025 01; 38(1):e13205.
-
Bansal R, Sener H, Ganguly A, Shields JA, Shields CL. Metastasis-free survival of uveal melanoma by tumour size category based on The Cancer Genome Atlas (TCGA) classification in 1001 cases. Clin Exp Ophthalmol. 2025 03; 53(2):175-183.